APrevent is a leading medical device company that specializes in providing innovative solutions for voice and speech disorders. Founded in 2013, the company is comprised of a team of skilled physicians and engineers dedicated to improving the quality of lives around the world. One of their flagship products is the APrevent® VOIS Vocal Implant System, an adjustable long-term implant designed to treat glottic insufficiency.

This cutting-edge solution offers a patient-oriented and physician-friendly approach to addressing voice and speech disorders. Additionally, APrevent offers AiSpeak, a speech conversion platform specifically developed for patients with dysarthria, a type of speech disorder. This innovative platform aims to enhance communication abilities and empower individuals to express themselves more effectively.

With subsidiaries in Austria and Taiwan, APrevent is committed to expanding its reach and impact globally. They have also received TFDA Approval, further validating the safety and efficacy of their products. For those interested in learning more about APrevent and their groundbreaking solutions, they can be contacted through their respective offices in Vienna or Taipei.

APrevent is dedicated to transforming lives through better voice and speech, creating a brighter future for individuals with speech disorders worldwide